Exchange: NASDAQ·Updated 07:01 AM EDT
GANX logo

GANX Gain Therapeutics Inc

$1.81
$0.01
(0.56%)
Pre-Market
Prev Close $1.80
Reported EarningsAug 11
Mkt Cap$77.25M
Vol778.00

About GANX

Gain Therapeutics, Inc. is a redefining drug discovery company, which identifies and optimizes allosteric binding sites that never targeted before. Its See-Tx target identification platform uses the published 3D structure of enzymes and a proprietary computational technology to discover new allosteric binding sites and predict their druggability. The firm is also unlocking new treatment options to treat disorders characterized by protein misfolding. The company was founded by Khalid Islam in 2017 and is headquartered in Bethesda, MD.
35

Bearish Sentiment

How do you feel about GANX?

Advertisement|Remove ads.